Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (5): 565-568.DOI: 10.3969/j.issn.1673-8640.2021.05.021
Previous Articles Next Articles
XIAO Yingyan, CUI Yan, LI Yan
Received:2020-01-14
Online:2021-05-30
Published:2021-05-30
CLC Number:
XIAO Yingyan, CUI Yan, LI Yan. Research progress of intestinal microbiota and IL-6/gp130 signaling pathway in acute pancreatitis pathogenesis[J]. Laboratory Medicine, 2021, 36(5): 565-568.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.05.021
| [1] | FORBES J D, VAN DOMSELAAR G, BERNSTEIN C N. The gut microbiotain immune-mediated inflammatory diseases[J]. Front Microbiol, 2016,7:1081. |
| [2] |
LUCAS LÓPEZ R, GRANDE BURGOS M J, GÁLVEZ A, et al. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease:a state of the science review[J]. APMIS, 2017,125(1):3-10.
DOI URL |
| [3] | PAGLIARI D, PICCIRILLO C A, LARBI A, et al. The interactions between innate immunity and microbiota in gastrointestinal diseases[J]. J Immunol Res, 2015,2015:898297. |
| [4] |
JANDHYALA S M, TALUKDAR R, SUBRAMANYAM C, et al. Role of the normal gut microbiota[J]. World J Gastroenterol, 2015,21(29):8787-8803.
DOI URL |
| [5] |
SARTOR R B, WU G D. Roles for intestinal bacteria,viruses,and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches[J]. Gastroenterology, 2017, 152(2):327-339.e4.
DOI URL |
| [6] | SIGNORETTI M, ROGGIOLANI R, STORNELLO C, et al. Gut microbiota and pancreatic diseases[J]. Minerva Gastroenterol Dietol, 2017,63(4):399-410. |
| [7] |
PUSHALKAR S, HUNDEYIN M, DALEY D, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression[J]. Cancer Discov, 2018,8(4):403-416.
DOI URL |
| [8] |
LESINA M, WÖRMANN S M, NEUHÖFER P, et al. Interleukin-6 in inflammatory and malignant diseases of the pancreas[J]. Semin Immunol, 2014,26(1):80-87.
DOI URL |
| [9] |
HABERMAN Y, TICKLE T L, DEXHEIMER P J, et al. Pediatric crohn disease patients exhibit specific ileal transcriptome and microbiome signature[J]. J Clin Invest, 2014,124(8):3617-3633.
DOI URL |
| [10] |
WLODARSKA M, KOSTIC A D, XAVIER R J. An integrative view of microbiome-host interactions in inflammatory bowel diseases[J]. Cell Host Microbe, 2015,17(5):577-591.
DOI URL |
| [11] |
ROOKS M G, GARRETT W S. Gut microbiota,metabolites and host immunity[J]. Nat Rev Immunol, 2016,16(6):341-352.
DOI URL |
| [12] | CLEMENTE J C, MANASSON J, SCHER J U. The role of the gut microbiome in systemic inflammatory disease[J]. BMJ, 2018,360:j5145. |
| [13] |
YU J, LIU Y, GUO J, et al. Health risk of Licorice-Yuanhua combination through induction of colonic H2S metabolism[J]. J Ethnopharmacol, 2019,236:136-146.
DOI URL |
| [14] |
WHITCOMB D C. Clinical practice. Acute pancreatitis[J]. N Engl J Med, 2006,354(20):2142-2150.
DOI URL |
| [15] |
SCHÜTTE K, MALFERTHEINER P. Markers for predicting severity and progression of acute pancreatitis[J]. Best Pract Res Clin Gastroenterol, 2008,22(1):75-90.
DOI URL |
| [16] | RINDERKNECHT H. Fatal pancreatitis,a consequence of excessive leukocyte stimulation?[J]. Int J Pancreatol, 1988,3(2-3):105-112. |
| [17] |
WAAGE A, BRANDTZAEG P, HALSTENSEN A, et al. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6,interleukin 1,and fatal outcome[J]. J Exp Med, 1989,169(1):333-338.
DOI URL |
| [18] |
SUZUKI S, MIYASAKA K, JIMI A, et al. Induction of acute pancreatitis by cerulein in human IL-6 gene transgenic mice[J]. Pancreas, 2000,21(1):86-92.
DOI URL |
| [19] |
ZHANG H, NEUHÖFER P, SONG L, et al. IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality[J]. J Clin Invest, 2013,123(3):1019-1031.
DOI URL |
| [20] |
ROBERTS S E, MORRISON-REES S, JOHN A, et al. The incidence and aetiology of acutepancreatitis across Europe[J]. Pancreatology, 2017,17(2):155-165.
DOI URL |
| [21] |
PETROV M S, YADAV D. Global epidemiology and holistic prevention of pancreatitis[J]. Nat Rev Gastroenterol Hepatol, 2019,16(3):175-184.
DOI URL |
| [22] |
LERCH M M, GORELICK F S. Models of acute and chronic pancreatitis[J]. Gastroenterology, 2013,144(6):1180-1193.
DOI URL |
| [23] |
PUSHALKAR S, HUNDEYIN M, DALEY D, et al. The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression[J]. Cancer Discov, 2018,8(4):403-416.
DOI URL |
| [24] | ANDERSSON R, WANG X D. Gut barrier dysfunction in experimental acute pancreatitis[J]. Ann Acad Med Singap, 1999,28(1):141-146. |
| [25] |
TAN C, LING Z, HUANG Y, et al. Dysbiosis of intestinal microbiota associated with inflammation involved in the progression of acute pancreatitis[J]. Pancreas, 2015,44(6):868-875.
DOI URL |
| [26] |
WU L M, SANKARAN S J, PLANK L D, et al. Meta-analysis of gut barrier dysfunction in patients with acute pancreatitis[J]. Br J Surg, 2014,101(13):1644-1656.
DOI URL |
| [27] |
LI Q, WANG C, TANG C, et al. Bacteremia in patients with acute pancreatitis as revealed by 16S ribosomal RNA gene-based techniques[J]. Crit Care Med, 2013,41(8):1938-1950.
DOI URL |
| [28] |
TSUJI Y, WATANABE T, KUDO M, et al. Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis[J]. Immunity, 2012,37(2):326-338.
DOI URL |
| [29] |
CLEMENTE J C, URSELL L K, PARFREY L W, et al. The impact of the gut microbiota on human health:an integrative view[J]. Cell, 2012,148(6):1258-1270.
DOI URL |
| [30] |
YU Y, RAKA F, ADELI K. The role of the gut microbiota in lipid and lipoprotein metabolism[J]. J Clin Med, 2019,8(12):2227.
DOI URL |
| [31] |
MATEY-HERNANDEZ M L, WILLIAMS F M K, POTTER T, et al. Genetic and microbiome influence on lipid metabolism and dyslipidemia[J]. Physiol Genom, 2018,50(2):117-126.
DOI URL |
| [32] |
WANG Z, KOONEN D, HOFKER M, et al. Gut microbiome and lipid metabolism:from associations to mechanisms[J]. Curr Opin Lipidol, 2016,27(3):216-224.
DOI URL |
| [33] |
FASSHAUER M, BLÜHER M. Adipokines in health and disease[J]. Trends Pharmacol Sci, 2015,36(7):461-470.
DOI URL |
| [34] |
BLÜHER M. Adipokines-removing road blocks to obesity and diabetes therapy[J]. Mol Metab, 2014,3(3):230-240.
DOI URL |
| [35] |
SKURK T, ALBERTI-HUBER C, HERDER C, et al. Relationship between adipocyte size and adipokine expression and secretion[J]. J Clin Endocrinol Metab, 2007,92(3):1023-1033.
DOI URL |
| [1] | ZHANG Han, LI Jun, LIU Xiaojiang, GUAN Yixiang. Role of serum albumin，interleukin-6 and ferritin combined determination in evaluating the functional prognosis of patients with spontaneous intracerebral hemorrhage [J]. Laboratory Medicine, 2023, 38(8): 713-718. |
| [2] | DING Xiaoyuan, DAI Jinsheng, JIAO Ronghong, MA Suli, ZHU Haifeng, WU Mengya, CHE Yanran, ZHANG Lei. Influence of obesity/overweight on inflammatory factors of Th1/Th2 and Th17/Treg in children with asthma attacks [J]. Laboratory Medicine, 2023, 38(8): 748-752. |
| [3] | WANG Haiping, LI He. BISAP score combined with serum sRAGE for predicting hyperlipidemic acute pancreatitis severity and short-term prognosis [J]. Laboratory Medicine, 2023, 38(7): 653-658. |
| [4] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [5] | WANG Xiaofei, FU Jiangtao, ZHU Shuangmei. Prognostic evaluation of IL-6 combined with YKL-40 in head and neck squamous cell carcinoma [J]. Laboratory Medicine, 2022, 37(6): 524-528. |
| [6] | ZHAI Shana, SUN Qinghai, YU Yongwu, YE Fang, LIU Maodong. Influence of vancomycin combined with meropenem on serum TNF-α,PCT,IL-6 and peritoneal fluid WBC count in PDRP patients [J]. Laboratory Medicine, 2022, 37(4): 360-364. |
| [7] | SONG Yunxiao, TONG Wei, ZHANG Haichen, ZHANG Yinwang, BIAN Xiaobo, ZHANG Linlin, YUAN Wenhua, ZHAO Zhiyun, GE Wen, YAO Tianyue. Correlation of systemic inflammatory markers and fracture occurrence in elderly patients with osteoporosis [J]. Laboratory Medicine, 2022, 37(3): 235-239. |
| [8] | ZHANG Yinwang, LIU Jinyu, SONG Yunxiao, GE Wen, ZHANG Linlin, YUAN Wenhua, ZHAO Zhiyun. Relationship between preoperative SII and postoperative infection in patients with open fracture after internal fixation [J]. Laboratory Medicine, 2022, 37(11): 1071-1074. |
| [9] | HE Xuelian, HE Ziyi, LIU Yueyang, YU Yanzhi, ZHANG Siying. Role of line chart model based on peripheral blood-derived inflammation markers in early diagnosis of neonatal septicemia [J]. Laboratory Medicine, 2022, 37(10): 921-927. |
| [10] | HU Bing, LI Gai, ZHANG Huimin. Roles of serum interleukin-6 and D-dimer levels in predicting the risk of cerebral hemorrhage in patients with hypertension [J]. Laboratory Medicine, 2022, 37(1): 63-67. |
| [11] | LI Caidong, ZHANG Xuqiang, LEI Zhiping, CHEN Qiaoli, CHEN Lu, TIAN Pengfei, DUAN Zhengjun. Clinical values of IL-1β,IL-6 and TNF-α in different clinical courses of chronic HBV infection [J]. Laboratory Medicine, 2021, 36(8): 790-794. |
| [12] | LIU Jinyan, ZHAO Juntao, XIANG Mingjie. Mechanism and application of serum amyloid A in clinical diseases [J]. Laboratory Medicine, 2021, 36(7): 756-760. |
| [13] | WANG Zipeng, OUYANG Changli, GENG Deqin, WANG Dunjing. Establishment of cerebrospinal fluid IL-6 reference interval in non-inflammatory central nervous system diseases [J]. Laboratory Medicine, 2021, 36(6): 627-630. |
| [14] | REN Yuan, ZHANG Min, YIN Xiang, ZENG Qianwen. Influence of intestinal flora on serum inflammatory factors in patients with chronic urticaria [J]. Laboratory Medicine, 2021, 36(5): 504-509. |
| [15] | LENG Deguo, YU Jinming, CAO Cheng, XU Hui. Clinical significance of reticulocyte parameters in acute pancreatitis [J]. Laboratory Medicine, 2021, 36(3): 296-299. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
